Literature DB >> 2509477

O-acetylation and de-O-acetylation of sialic acids. O-acetylation of sialic acids in the rat liver Golgi apparatus involves an acetyl intermediate and essential histidine and lysine residues--a transmembrane reaction?

H H Higa1, C Butor, S Diaz, A Varki.   

Abstract

Isolated intact rat liver Golgi vesicles utilize [acetyl-3H]coenzyme A to add 3H-O-acetyl esters to sialic acids of internally facing endogenous glycoproteins. During this reaction, [3H]acetate also accumulates in the vesicles, even though the vesicles are impermeant to free acetate. On the other hand, entry of intact AcCoA into the lumen of the vesicles could not be demonstrated, and permeabilization of the vesicles did not alter the reaction substantially (Diaz, S., Higa, H. H., Hayes, B. K., and Varki, A. (1989) J. Biol. Chem. 264, 19416-19426). When vesicles prelabeled with [acetyl-3H] coenzyme A are permeabilized with saponin, we can demonstrate a [3H]acetyl intermediate in the membrane that can transfer label to the 7- and 9-positions of exogenously added free N-acetylneuraminic acid but not to glucuronic acid or CMP-N-acetylneuraminic acid. This labeled acetyl intermediate represents a significant portion of the radioactivity incorporated into the membranes during the initial incubation and cannot be accounted for by nonspecifically "trapped" acetyl-CoA in the permeabilized vesicles. There was no evidence for involvement of acetylcarnitine or acetyl phosphate as an intermediate. The overall acetylation reaction appears to involve two steps. The first step (utilization of exogenous acetyl-CoA to form the acetyl intermediate) is inhibited by coenzyme A-SH (apparent Ki = 24-29 microM), whereas the second (transfer from the acetyl intermediate to sialic acid) is not affected by millimolar concentrations of the nucleotide. Studies with amino acid-modifying reagents indicate that 1 or more histidine residues are involved in the first step of the acetylation reaction. Diethylpyrocarbonate (which can react with both nonsubstituted and singly acetylated histidine residues) also blocks the second reaction, indicating that the acetyl intermediate on both sides of the membrane involves histidine residue(s). Taken together with data presented in the preceding paper, these results indicate that the acetylation of sialic acids in Golgi vesicles may occur by a transmembrane reaction, similar to that described for the acetylation of glucosamine in lysosomes (Bame, K. J., and Rome, L. H. (1985) J. Biol. Chem. 260, 11293-11299). However, several features of this Golgi reaction distinguish it from the lysosomal one, including the nature and kinetics of the reaction and the additional involvement of an essential lysine residue. The accumulation of free acetate in the lumen of the vesicles during the reaction may occur by abortive acetylation (viz. transfer of label from the acetyl intermediate to water). It is not clear if this is an artifact that occurs only in the in vitro reaction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2509477

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Highly efficient chemoenzymatic synthesis of naturally occurring and non-natural alpha-2,6-linked sialosides: a P. damsela alpha-2,6-sialyltransferase with extremely flexible donor-substrate specificity.

Authors:  Hai Yu; Shengshu Huang; Harshal Chokhawala; Mingchi Sun; Haojie Zheng; Xi Chen
Journal:  Angew Chem Int Ed Engl       Date:  2006-06-12       Impact factor: 15.336

2.  Characterization of gentamicin 2'-N-acetyltransferase from Providencia stuartii: its use of peptidoglycan metabolites for acetylation of both aminoglycosides and peptidoglycan.

Authors:  K G Payie; A J Clarke
Journal:  J Bacteriol       Date:  1997-07       Impact factor: 3.490

3.  Assays of sialate-O-acetyltransferases and sialate-O-acetylesterases.

Authors:  G Vinayaga Srinivasan; Roland Schauer
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

4.  Genomic and metabolic profiling of nonulosonic acids in Vibrionaceae reveal biochemical phenotypes of allelic divergence in Vibrio vulnificus.

Authors:  Amanda L Lewis; Jean-Bernard Lubin; Shilpa Argade; Natasha Naidu; Biswa Choudhury; E Fidelma Boyd
Journal:  Appl Environ Microbiol       Date:  2011-07-01       Impact factor: 4.792

5.  Enzymatic 4-O-acetylation of N-acetylneuraminic acid in guinea-pig liver.

Authors:  M Iwersen; V Vandamme-Feldhaus; R Schauer
Journal:  Glycoconj J       Date:  1998-09       Impact factor: 2.916

6.  O-acetylation of Arabidopsis hemicellulose xyloglucan requires AXY4 or AXY4L, proteins with a TBL and DUF231 domain.

Authors:  Sascha Gille; Amancio de Souza; Guangyan Xiong; Monique Benz; Kun Cheng; Alex Schultink; Ida-Barbara Reca; Markus Pauly
Journal:  Plant Cell       Date:  2011-11-15       Impact factor: 11.277

7.  Uptake and incorporation of an epitope-tagged sialic acid donor into intact rat liver Golgi compartments. Functional localization of sialyltransferase overlaps with beta-galactosyltransferase but not with sialic acid O-acetyltransferase.

Authors:  R Chammas; J M McCaffery; A Klein; Y Ito; L Saucan; G Palade; M G Farquhar; A Varki
Journal:  Mol Biol Cell       Date:  1996-11       Impact factor: 4.138

8.  Discovery and characterization of sialic acid O-acetylation in group B Streptococcus.

Authors:  Amanda L Lewis; Victor Nizet; Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

9.  Sialic acid 9-O-acetylesterase catalyzes the hydrolyzing reaction from alacepril to deacetylalacepril.

Authors:  Shigeyuki Usui; Masafumi Kubota; Kazuhiro Iguchi; Tadashi Kiho; Tadashi Sugiyama; Yoshihiro Katagiri; Kazuyuki Hirano
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

10.  Genetic and biochemical modulation of sialic acid O-acetylation on group B Streptococcus: phenotypic and functional impact.

Authors:  Shannon Weiman; Samira Dahesh; Aaron F Carlin; Ajit Varki; Victor Nizet; Amanda L Lewis
Journal:  Glycobiology       Date:  2009-07-30       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.